Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 26.6.2017 | EN | Official Journal of the European Union | C 202/27 |

---

Action brought on 9 May 2017 — Kwizda Holding v EUIPO — Dermapharm (UROAKUT)

(Case T-266/17)

(2017/C 202/43)

Language in which the application was lodged: German

Parties

Applicant: Kwizda Holding GmbH (Vienna, Austria) (represented by: L. Wiltschek, D. Plasser and K. Majchrzak, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Dermapharm GmbH (Vienna, Austria)

Details of the procedure before EUIPO

Party applying for the mark at issue: Applicant

Mark at issue: EU word mark ‘UROAKUT’ — application No 13 854 146

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 7 March 2017 in Case R 1221/2016-4

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | uphold the action and amend the contested decision in such a way that the opposition to the EU trade mark application No 13 854 146 UROAKUT is rejected; in the alternative, annul the contested decision and refer the case back to the Board of Appeal of the European Union Intellectual Property Office (EUIPO); |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs of the proceedings before the General Court and before the Board of Appeal; |

|  |  |
| --- | --- |
| — | order the intervener to pay the costs incurred in the proceedings before the Opposition Division. |

Plea in law

|  |  |
| --- | --- |
| — | infringement of Article 8(1)(b) of Regulation No 207/2009. |

---

[Top](#document1)